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Abstract
Thyroid hormone entry into cells is facilitated by transmembrane transporters. Mutations of the specific thyroid hormone
transporter, MCT8 (Monocarboxylate Transporter 8, SLC16A2) cause an X-linked syndrome of profound neurological
impairment and altered thyroid function known as the Allan-Herndon-Dudley syndrome. MCT8 deficiency presumably
results in failure of thyroid hormone to reach the neural target cells in adequate amounts to sustain normal brain
development. However during the perinatal period the absence of Mct8 in mice induces a state of cerebral cortex
hyperthyroidism, indicating increased brain access and/or retention of thyroid hormone. The contribution of other
transporters to thyroid hormone metabolism and action, especially in the context of MCT8 deficiency is not clear. We have
analyzed the role of the heterodimeric aminoacid transporter Lat2 (Slc7a8), in the presence or absence of Mct8, on thyroid
hormone concentrations and on expression of thyroid hormone-dependent cerebral cortex genes. To this end we
generated Lat2-/-, and Mct8-/yLat2-/- mice, to compare with wild type and Mct8-/y mice during postnatal development. As
described previously the single Mct8 KO neonates had a transient increase of 3,5,39-triiodothyronine concentration and
expression of thyroid hormone target genes in the cerebral cortex. Strikingly the absence of Lat2 in the double Mct8Lat2 KO
prevented the effect of Mct8 inactivation in newborns. The Lat2 effect was not observed from postnatal day 5 onwards. On
postnatal day 21 the Mct8 KO displayed the typical pattern of thyroid hormone concentrations in plasma, decreased cortex
3,5,39-triiodothyronine concentration and Hr expression, and concomitant Lat2 inactivation produced little to no
modifications. As Lat2 is expressed in neurons and in the choroid plexus, the results support a role for Lat2 in the supply of
thyroid hormone to the cerebral cortex during early postnatal development.
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Introduction
Thyroid hormones (thyroxine, T4 and 3,5,39-triiodo-L-thyro-
nine, T3) transport through the cellular plasma membrane is
facilitated by several classes of transmembrane proteins. These
include the monocarboxylate transporters (MCT), the organic
anion transporter polypeptides (OATP), the heterodimeric ami-
noacid transporters, the Na+/taurocholate cotransporting poly-
peptide (NTCP) and other classes of transporters [1]. MCT8
(SLC16A2) is specific for iodothyronine transport [2,3]. MCT8
gene mutations cause an X-linked thyroid hormone cell transport
defect, also known as Allan-Herndon-Dudley syndrome, charac-
terized by global developmental delays, profound neurological
impairment, severe intellectual deficit, and altered secretion,
distribution and metabolism of thyroid hormones [4–6]. Patients
also present elevated serum T3, reduced T4 and rT3, and
unaltered or slightly elevated serum TSH.
Thyroid hormone acts on the brain from early brain
development [7–9]. The neurological impairment of MCT8
transport defect is likely due to the failure of thyroid hormone to
reach the neural target cells in adequate amounts to sustain
normal brain development. The syndrome is partially replicated in
mice with inactivated Mct8 gene [10,11]. These Mct8-deficient
mice display the same alterations of thyroid hormone concentra-
tions as the patients, indicating that the absent or defective
function of the Mct8 protein in mice leads to similar alterations of
thyroid hormone as those found in patients. However these mice
present minimal, if any, behavioral deficits of uncertain etiology
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[12], and do not show the anatomical alterations typical of brain
hypothyroidism during postnatal development [12,13]. Further-
more, the expression of most thyroid hormone-dependent genes in
the cerebral cortex of juvenile Mct8-deficient mice is similar to the
wild type (Wt) mice [14]. The major role of Mct8 seems to be that
of facilitating the transport of T4 and T3 through the blood-brain
barrier [13,15]. However, T4 also enters the brain through
another transporter from the Oatp family, Oatp1c1 (Slco1c1, or
Oatp14) [16,17]. It has been proposed that this transport route
delivers T4 to the astrocytes, where T4 to T3 conversion takes
place, in a reaction catalyzed by type 2 deiodinase [18–21].
Therefore, in the presence of functionally defective Mct8 protein,
entry of circulating T3 into the brain is restricted. Nevertheless
enough T3 is still formed locally in the brain to sustain thyroid
hormone-dependent gene expression [14].
The in vivo role of other classes of thyroid hormone transporters
in the brain is uncertain. As can be concluded from the paragraph
above, T3 formed in the astrocytes can readily reach the neurons
in the absence of Mct8, indicating that other transporters may be
involved in this process. Among others, the L-type amino acid
transporters 1 and 2 have been suggested to compensate for the
lack of Mct8 in mice [12], and have been implicated in T3
transport in astrocytes and neurons [22]. Lat2 is highly expressed
in the postnatal mouse cerebral cortex and has been proposed to
participate together with Mct8 in T3 transport in primary
astrocyte culture [22]. We have generated mice deficient in both
Mct8 and Lat2 to investigate whether the combined absence of
both transporters impairs T3 action in the brain more severely
than in the case of Mct8 deficiency alone.
Our results indicate that Lat2 is mostly dispensable for T3
action. However it was previously reported that newborn Mct8-
deficient mice unexpectedly showed increased expression of
thyroid hormone-dependent genes in the cerebral cortex, indicat-
ing a perinatal state of cerebral hyperthyroidism [23]. In the
present work we show that Lat2 inactivation transiently blocks this
early effect of Mct8 deficiency. Furthermore, Lat2 is expressed
predominantly in neurons. The results support that Lat2 has a role
in T3 delivery to neurons during the perinatal period.
Materials and Methods
Ethics statement: All experimental procedures involving animals
were performed following the European Union Council guidelines
(directive 2010/63/UE) and Spanish regulations (R.D.1201/2005,
and Law 32/2007) and in accordance with University of Chicago
Institutional Animal Care and Use Committee. They were
approved by the ethics committee of our institution (Consejo
Superior de Investigaciones Cientı´fias, CSIC; approval number
SAF2011-25608).
Animals were housed in temperature (2262uC) and light (12:12
light-dark cycle; lights on at 7 a.m.) controlled conditions and had
free access to food and water. Euthanasia was performed by
decapitation. For in situ hybridization, the mice were first
anesthetized with ketamine (50 mg/g BW) and medetomidine
hydrochloride (0.1 mg/g BW) and perfused with 4% paraformal-
dehyde in 0.1 M phosphate buffered saline pH 7.4. Mct8 (Slc16a2)
KO mice (male genotype, Mct8-/y) originated from the line
generated by one of the coauthors (AMD) [10]. Experiments were
carried out on Wt and KO male littermates derived from back
crossing of heterozygous females with Wt males of the C57BL/6J
strain. The Mct8 genotype was confirmed as described [13].
The Lat2 (Slc7a8) KO mouse line was generated in a mixed
genetic background of C57/129Ola. Briefly, a vector with
homology arms of 6.1 kb and 2.3 kb was generated, and replaced
part of the promoter and exon 1 of Slc7a8 with the neomycin
resistance gene. Homologous recombination was performed by
GenOway (Lyon, France). Eight male chimeras were crossed with
C57BL/6J females to obtain the F1 generation. F1 heterozygotes
(Slc7a 8+/2) were intercrossed obtaining the three possible
genotypes following a mendelian frequency. A detailed description
of the procedure and the full characterization of the phenotype
will be reported [24]. To generate the animals used in the
experiments we started by crossing Mct8x/yLat2-/- males with
Mct8-/xLat2+/+ females. Then Mct8x/yLat22/+ males were crossed
with Mct8-/xLat22/+ females. From the genotypes obtained we
crossed Mct8x/yLat2+/+ (Wt) males with Mct8-/xLat2+/+ females to
generate Wt and Mct8 KO male littermates. Similarly, we crossed
Mct8x/yLat2-/- males with Mct8-/xLat2-/- females to generate Lat2
KO and Mct8Lat2 KO male littermates. The Lat2 genotype was
confirmed by PCR of tail DNA (36 cycles at 62 C annealing
temperature) using the following primers:
forward common: 59GGAGCGATCTGCGGAGTGA39;
reverse Wt-specific: 59ACAGAGTGCGCTCCTACCCT39;
reverse KO-specific: 59CGGTGGGCTCTATGGGTCTA39.
This procedure generates a 457 bp fragment from the Wt allele
and a 180 bp fragment from the null allele.
Experiments were performed on Wt, Mct8 KO (M8), Lat2 KO
(L2), and Mct8Lat2 KO (M8L2) at postnatal (P) day 0, P5, P15, and
P21. Most experiments were performed using 8 animals per group.
Trunk blood was collected in heparinized tubes after decapitation,
and the liver was frozen on dry ice and stored at 280uC. The
brain was removed and the neocortex was rapidly dissected out
from underlying structures, divided in two halves through the
sagittal cut, blotted on filter paper, weighed and frozen on dry ice.
Thyroid hormone concentration in plasma and cerebral cortex
was determined as previously described [25]. We used 30 ml of
pooled plasma from 2–3 P0 mice, or hemi cortices pooled from 3
mice. For P5 and P21 mice we used individual 50 ml aliquots of
plasma, or individual hemi cortices. Under the conditions of the
assays, the limits of detection at P0 were: 1.67 ng/ml for plasma
T4, 0.03 ng/ml for plasma T3, and 0.37 ng/g for cortex T3.
RNA was isolated from individual hemi cortices for P5, P15, and
P21 mice and from the whole cortex from individual P0 mice, and
liver. Expression of the following thyroid hormone-dependent
genes was measured by qPCR: Hr (Hairless); Sema7a (Semaphorin
7a); Klf9 (Kruppel-like factor 9, also known as Basic Transcription
Element Binding protein, BTEB); Aldh1a1, Aldh1a3 (Aldehyde
dehydrogenases 1a1 and 1a3); Slc1a3 (glial high affinity glutamate
transporter), and Dio1 (Type 1 iodothyronine deiodinase). Proce-
dures for RNA isolation and qPCR were identical to those
previously described [14]. Data were expressed relative to the
values obtained on tissues from the Wt, mice which were given a
mean value of 1.0 after correction for 18S RNA. In situ mRNA
hybridization analysis for Lat2 and the double in situ hybridization
and immunohistochemistry were performed using methods
previously described in detail [26]. The 35S Lat2 riboprobe was
synthesized from a 390 base pairs DNA template obtained by
PCR amplification with the following primers: forward 59-
GCCTGCTGTTTCCCATTATC-39, reverse 59-CAGGAATA-
CAGGGCAGAAAG-39. The antibodies used for immunohisto-
chemistry were against the neuronal nuclear protein NeuN
(Chemicon, Millipore, final dilution 1/500), and the astrocytic
glial fibrillary acidic protein (GFAP, Sigma Chemical Co, final
dilution 1/2000).
Data were analyzed by one-way ANOVA and the Tukey
posthoc test using the GraphPad software (www.graphpad.com).
The P0 data were checked for a maternal effect using a General
Lineal Model with the SPSS package. This was due to the
Role of Lat2 in Thyroid Hormone Transport
PLOS ONE | www.plosone.org 2 May 2014 | Volume 9 | Issue 5 | e96915
impossibility to obtain littermates of all genotypes for the
experiments. As described above, the Wt and Mct8 KO mice
were littermates from Mct8-/xLat2+/+ mothers. The Lat2 KO and
Mct8Lat2 KO mice were littermates from Mct8-/xLat2-/- mothers.
The possibility that any change observed, especially at P0, was due
to differences in the maternal genotype was discarded by the
General Lineal Model analysis.
Results
Lat2 expression in the brain
Lat2 expression was studied in the cerebrum of P0 and P21 mice
by in situ hybridization using a Lat2 specific riboprobe (Fig 1). At
P0 Lat2 was expressed in neocortical layers, the piriform cortex,
the hippocampus and the thalamus (Fig 1C, D). At P21, Lat2 was
expressed in the neocortex, the pririform cortex, the pyramidal
and granular cell layers of the hippocampus, the amygdala, and
the thalamus, with high expression in the thalamic paraventricular
nucleus (Fig 1E, F). Hybridization signal was also observed in the
choroid plexus of the lateral ventricles at both ages. There was
little expression in the striatum and the hypothalamus. The in situ
hybridization pattern was compatible with a predominant
expression in neurons. This was confirmed by in situ hybridization
on brain slices of P21 mice using a 35S-Lat2 riboprobe combined
with immunohistochemistry for NeuN in neurons and GFAP in
astrocytes (Fig 1G, H). While neurons were clearly labeled,
astrocytes were not. These results agree with the data from the
transcriptomic database of Cahoy et al [27] that Lat2 is expressed
in neurons and not in astrocytes when primary brain cell cultures
were analyzed, though in cultured astroglial cells Lat2 expression
becomes significant, explaining results from other authors [22].
Thyroid hormone concentrations
The plasma T4 and T3 concentrations at P0, P5, and P21 are
shown in figure 2. On P0 T4 was increased in the mice lacking
Mct8, with significant differences between M8 and Wt and
between M8L2 and L2. There was no difference between Wt and
L2. By P5 the T4 concentration in the M8 was still slightly elevated
although the difference with the Wt was not significant. In the L2
mice T4 showed a tendency to be lower than in the other groups,
although the difference was significant only when compared to the
M8. By P21 plasma T4 was 60% lower in the M8 mice, as
expected, and 35% in the L2 mice compared to Wt. The M8L2
mice showed similar T4 values as the M8 indicating that the lack
of Mct8 determined the T4 concentration in the double KO.
The plasma T3 concentration on P0 was reduced in the M8
mice compared to the Wt. On P5 the mean T3 concentration was
higher in the M8 than in the Wt, although the difference was not
significant. T3 in the L2 was lower than in the M8 or L2M8 mice.
By P21 plasma T3 showed the expected changes in the M8 mice,
with a 37% increase. Lat2 deficiency alone was associated with
25% decrease of T3. In the M8L2 mice T3 was lower than in the
M8 only mice, indicating that the absence of Lat2 moderated the
effect of Mct8 inactivation on the T3 concentration.
The bottom panel of Fig 2 shows the T3 concentrations in the
cerebral cortex. On P0 there was a 40% increase of T3 in the M8
mice, without changes in the L2 or M8L2 mice. On P5 cortex T3
was increased in the M8 and the M8L2 mice. On P21, T3 was
decreased in the cortex of M8 and M8L2 mice, in agreement with
the known effect of Mct8 inactivation at this age [11]. Inactivation
of Lat2 only also decreased T3 in the cortex at P21, correlating
with the decreased serum T3 and T4.
Effects of thyroid hormone transporter deficiency on
cerebral cortex gene expression
Fig 3 shows the effects of transporter inactivation on the
expression of thyroid hormone-dependent genes in the cerebral
cortex. RNA was prepared from the cerebral cortex of Wt, M8, L2,
and M8L2 mice at P0, P5, P15, and P21. Expression of three
sensitive T3-responsive genes Hr, Sema7a and Klf9 was measured
by qPCR in all genotypes at all ages. In agreement with recent
findings [23] at P0 Hr expression in the cortex was increased by
32% in the M8 mice. We also found that Hr expression decreased
in the L2 mice by 27%. Remarkably, the double M8L2 mice did
not show the increased Hr expression over the Wt observed in the
M8 only mice, indicating that normal expression of Lat2 was
required for this effect. The two other genes, Sema7a and Klf9
showed changes similar to Hr. Sema7a expression was increased by
35% in the M8 mice, decreased by 25% in the L2 mice, and again
Figure 1. Lat2 expression. A–D: P0: A and B are Nissl staining and C
and D in situ hybridization radioautographs. E and F: P21 in situ
hybridization radioautographs. Abbreviations: chp, choroid plexus; CTX,
cerebral neocortex; CA, cornus Ammonis; CPu, caudate-putamen; DG,
dentate gyrus; Hy, hypothalamus, Hip, hippocampus; Th, thalamus; PVT,
thalamic paraventricular nucleus; LA, lateral amygdala. G: in situ
hybridization (P21) with 35S-Lat2 probe combined with immunohisto-
chemistry for NeuN to reveal neurons. Hippocampal CA1 field. H: Similar
field as G, but at lower magnification, with cells stained for glial fibrillary
acidic protein (GFAP). The majority of the silver grains can be seen on
the neuronal pyramidal layer (asterisk) with background signal on the
astrocytes. Scale bars were 1 mm in C–D, E and F, and 50 mm in G and H.
doi:10.1371/journal.pone.0096915.g001
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Lat2 inactivation suppressed the effect of Mct8 deficiency. Klf9
increased by 85% in the M8, and did not change in the L2 mice.
As with Hr and Sema7a, the increase in M8 was suppressed by L2
inactivation in the M8L2 mice. Other thyroid hormone-responsive
genes, Aldh1a1, Aldh1a3, and Slc1a3 showed no changes in any of
the phenotypes (data not shown).
The increased Hr expression caused by Mct8 inactivation at P0
was still observed at P5 with the important difference that at this
age there was no suppressive effect of the additional Lat2
inactivation. The Sema7a and Klf9 responses were somewhat
variable, with an increased expression in the M8L2 mice. After a
transition at P15, with similar expression of the three genes in all
genotypes, a 40% reduction of Hr expression was observed at P21
in the M8, without changes in Sema7a and Klf9, in agreement with
previous findings [14]. There were no effects of Lat2 inactivation,
and the combined Mct8Lat2 deficiency had the same effect as the
Mct8 deficiency alone. For comparison, induction of hypothy-
roidism by administration of antithyroid drugs [13] caused a 38%
decrease of Hr expression at P0 and 85% decrease at P21 (data not
shown).
Finally, we measured the expression of liver Dio1, a sensitive
marker of peripheral thyroid status [10,28] (Fig 4). At P0 Dio1
mRNA abundance was very low, near the limit of detection by
qPCR, and was more easily measured in the rest of the groups due
to an increased expression over the Wt values. In the M8 mice Dio1
expression increased 7 fold at P0 and 3 fold at P5-P21. While the
single Lat2 inactivation did not modify Dio1 expression, the
combined Lat2 and Mct8 inactivation led to a synergistic 15 fold
increase in the M8L2 mice at P0. At P5 the M8L2 mice still
showed the highest mean value of all groups but the difference
from M8 was not significant.
Figure 2. Plasma T4 and T3 and cortex T3 concentrations in mice of different genotypes and different ages, as indicated. Wt = wild
type mice; M8 = Mct8KO. L2 = Lat2KO; M8L2 = Mct8Lat2KO. Significance of differences was calculated by one way ANOVA, and the Tukey posthoc
test. Only relevant significant comparisons are indicated. * P,0.05. ** P,0.01. *** P,0.001. P0, P5, and P21: postnatal days 0, 5, and 21, respectively.
doi:10.1371/journal.pone.0096915.g002
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Discussion
The goal of the present work was to evaluate the contribution of
Lat2, as a secondary thyroid hormone transporter, to thyroid
hormone action in the brain. Our approach was to study the
expression of thyroid hormone dependent genes in the cerebral
cortex in a mouse deficient in Lat2. However, given the possible
redundancy of different transporters we also analyzed the effect of
Lat2 deficiency in the absence of Mct8. The reason for this
approach is that, even if no effect of Lat2 deficiency only were
observed, it is entirely possible that Lat2 cooperates with Mct8 and
other transporters in thyroid hormone metabolism and action. In
this context, the thyroid hormone transporter function of Lat2
[12], like that of other transporters such as Oatp1c1 [16,29], might
compensate for the Mct8 deficiency in the mouse brain. Lack of
similar compensation in the human brain might explain the
discordant neurological phenotypes of Mct8KO mice and MCT8
deficient patients.
A previous analysis of a different strain of Lat2KO mice found
in adult mice a mild phenotype, with aminoaciduria, normal
growth, and altered performance in the rotarod test, indicating
light neurobehavioral alterations [30]. Mice had no obvious
defects of thyroid hormone signaling, and had normal serum
Figure 3. Gene expression (mean ± SE) in the cerebral cortex and liver of mice of different genotypes and ages as indicated. Wt=
wild type mice; M8 = Mct8KO; L2 = Lat2KO; M8L2 = Mct8Lat2KO. Measurements were by qPCR, and the data expressed relative to 18S RNA.
Significance of differences was calculated by one way ANOVA and the Tukey posthoc test. Only relevant significant comparisons are indicated. * P,
0.05. ** P,0.01. *** P,0.001. Hr: Hairless mRNA. Sema7a: Semaphorin 7a mRNA. Klf9: Kruppel factor 9, or BTEB mRNA. P0, P5, P15, P21: postnatal days
0, 5, 15, or 21.
doi:10.1371/journal.pone.0096915.g003
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concentrations of thyroid hormones and TSH, normal cerebellar
development, and normal expression of the T3 target genes RC3
(Nrgn), Hr, and Dio3 in the cerebellum and the cerebral cortex, and
of Dio1 in liver and kidney. In general these results agree with ours,
and we did not find signs of delayed cerebellar development in the
Lat2KO only mice as well as in the double Mct8Lat2KO mice
(results not shown). We also found altered rotarod performance in
the adult Lat2KO mice that was not worsened by concomitant
Mct8 deficiency (data not shown). In our strain of mice, Lat2-
deficiency had a mild effect on circulating thyroid hormone
concentrations in juvenile animals, with decreased T4 and slightly
decreased T3 at P21. These hormonal changes, however, did not
result in tissue hypothyroidism, in liver or brain, with normal
expression of Dio1 and Hr, respectively. On the other hand the
Mct8-deficient mice had the expected changes of circulating T4
and T3 [10], and the double Mct8Lat2KO mice mostly resemble
the Mct8KO only mouse. Increased Dio1 mRNA in the Mct8KO or
Mct8Lat2KO at P21 paralleled the plasma T3 increase in these
groups. Our findings, together with the previous findings by Braun
et al [30] indicate that Lat2 has little contribution to thyroid
hormone economy at least from the late postnatal period.
Despite this conclusion, Lat2 might be relevant to thyroid
hormone transport in the brain during the perinatal period. As
already reported [23] the newborn Mct8KO mice showed an
unexpected cerebral cortex hyperthyroidism as reflected in the
expression of the thyroid hormone-regulated genes Hr, Sema7a,
and Klf9, which is not due to immaturity of the brain barriers
[23,31]. Lat2 is required for the hyperthyroid effect of Mct8
deficiency, at least at P0. At this age Lat2 deficiency blocks the
increased gene expression and cortex T3 concentration observed
in the absence of Mct8. However the specific pathway controlled
by Lat2 is not apparent. As in the earlier study [23] we found here
that plasma T4 was increased in the Mct8KO mice, and also in the
Mct8Lat2KO. T3 was however decreased in the plasma at P0
supporting the view that cerebral hyperthyroidism is not due to
increased uptake of T3 by the brain, and correlates better with the
increased circulating T4. This suggests that the cortex hyperthy-
roidism is due to either increased local production of T3 from T4,
or to retention of T3 in the cortex. The latter could indicate that
the absence of Mct8 interferes with T3 efflux [23] and/or with its
degradation by D3 in neurons [32] leading to T3 accumulation.
The specific role of Lat2 is not evident but given its neuronal
expression, it is reasonable to think that it has relevant role in T3
influx into the neurons during the perinatal period.
Liver Dio1 was increased in the M8 mice at P0 as already
reported [23]. This change takes place in the face of a lower
plasma T3 concentration than in the Wt, as shown in this work,
and in the presence of an increased hepatic T4 content at E18 and
P0 [23] consistent with a role of Mct8 in thyroid hormone efflux.
Interestingly we found that the Lat2 and Mct8 deficiencies have a
synergistic effect on Dio1 expression at P0, reminiscent of what
happens with the combined Mct8 and Mct10 deficiency in older
animals [33]. This supports the view that during the perinatal
period Lat2 has a role in thyroid hormone efflux at least in the
liver.
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